• CoreWeave tripled Q2 revenue to $1.2 billion, but operating margin fell to 2% and net losses widened to $290 million.
  • Shares dropped 10% in after-hours trading, with analysts warning that hardware depreciation and rising costs may mask deeper losses.
  • Investor skepticism mounts as CoreWeave faces tough questions about profitability, resilience, and its $9 billion bid for Core Scientific.

CoreWeave, one of the hottest names in AI infrastructure, reported Q2 revenue of $1.2 billion—tripling year over year and reflecting massive growth in AI compute demand.

Yet, booming sales failed to buoy investor sentiment as swelling costs, thinner margins, and widening losses weighed heavily, sending CoreWeave’s stock down 10% in after-hours trading.

The company’s operating margins shrank to just 2%, a steep drop from 20% a year ago, squeezing CoreWeave’s bottom line despite its $30 billion multi-year revenue backlog.

Net losses surged to $290 million for the quarter amid heavier interest costs, infrastructure spending, and generous stock-based compensation.

CEO Michael Intrator said CoreWeave continues to “scale rapidly” to meet “unprecedented AI demand,” but acknowledged expenses are racing ahead of profits.

Analysts cautioned that CoreWeave’s actual financial health may be even weaker than reported, flagging optimistic depreciation assumptions for current-generation GPUs and noting rivals are fast closing the hardware gap.

“Without faster margin expansion and locked-in utilisation, they risk sliding from high-growth disruptor to low-return infrastructure landlord,” said Ram Kumar of OpenLedger.

Meanwhile, resistance is growing to CoreWeave’s proposed $9 billion buyout of Core Scientific, with top shareholders calling the deal “inadequate” and exposing CoreWeave to additional economic risk.

CoreWeave’s future now hinges on margin improvement and sustained demand for AI compute, while it races to maintain its edge in a volatile, capital-intensive market.

Edited by Annette George